Patent details

EP1567155 Title: ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS

Basic Information

Publication number:
EP1567155
PCT Application Number:
PCT/US/2003/038672
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP037903580
PCT Publication Number:
WO/2004/053072
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS
French Title of Invention:
ADMINISTRATION DE CELLULES DENDRITIQUES PARTIELLEMENT MATURES IN VITRO POUR LE TRAITEMENT DE TUMEURS
German Title of Invention:
VERABREICHUNG TEILGEREIFTER DENDRITISCHER ZELLEN IN VITRO ZUR BEHANDLUNG VON TUMOREN
SPC Number:

Dates

Filing date:
05/12/2003
Grant date:
27/10/2010
EP Publication Date:
27/10/2010
PCT Publication Date:
24/06/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/08/2005
EP B1 Publication Date:
27/10/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/12/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/12/2010
 
 

Name:
NorthWest Biotherapeutics Inc.
Address:
4800 Montgomery Lane, Suite 800, Bethesda. MD 20814, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
29/10/2010
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
BOSCH Marnix, L.
Address:
United States (US)

Priority

Priority Number:
431267 P
Priority Date:
06/12/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 5/0784;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/06/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
30/04/2018 Outgoing Correspondence 1
30/04/2019 Outgoing Correspondence 1